Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk's GLP-1 agonist Ozempic has become the first drug in the class to be approved by the FDA to reduce the risk of ...

Whether you’ve been prescribed Mounjaro (tirzepatide) for type 2 diabetes, weight loss, or both, you’re likely wondering what to eat (and not to eat) while taking the medication. After all ...

Whether you’ve been prescribed Mounjaro (tirzepatide) for type 2 diabetes, weight loss, or both, you’re likely wondering what to eat (and not to eat) while taking the medication. After all, a healthy ...